Regenerative medicine as a clinical strategy for active longevity: from tissue restoration to functional recovery

Modern gerontology is increasingly shifting its focus from a formal increase in life expectancy to the preservation of functional ability, autonomy and meaningful recovery in older adults. In this context, regenerative medicine should not be considered only as a set of high-technology cellular, tissue-engineering or transplantation interventions, but rather as a clinical strategy aimed at functional recovery. Aim of this study is to substantiate a clinical and organizational framework for the responsible implementation of regenerative approaches in a multidisciplinary hospital from the perspective of active longevity and functional outcomes. Material and methods. A conceptual analytical review was performed, covering healthy ageing, geroscience, regenerative medicine, cellular technologies, transplantation, wound care and orthobiological interventions. Results. The key clinical domains of regenerative medicine relevant to older and comorbid patients include organ replacement transplantation, hematopoietic recovery, reconstructive wound care, vascular and perfusion-oriented approaches, orthobiology and bone-restorative surgery. A transition from technology-driven implementation to a clinical model based on patient selection, protocol standardization, safety monitoring and functional outcome assessment is essential. Conclusion. Regenerative medicine may become a practical component of active longevity medicine if its endpoint is not merely tissue restoration, but the preservation of mobility, independence, exercise tolerance and social participation.